Related Experiment Video

Updated: Aug 8, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Cholesterol-lowering and vascular reactivity in relation to coronary heart disease

M de Divitiis1, P Rubba

  • 1Department of Clinical and Experimental Medicine, Federico II University Medical School, Naples, Italy.

Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|August 28, 1999
PubMed

Insights

Cholesterol-lowering treatments improve coronary heart disease prognosis by restoring vascular relaxation capacity, not just plaque regression. This highlights a key mechanism in cardiovascular disease management.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Vascular Biology

Background:

  • Cholesterol-lowering treatments are proven for coronary heart disease (CHD) prevention.
  • A discrepancy exists between prognostic benefits and plaque regression effects of these treatments.
  • Hypercholesterolemia impairs vascular reactivity.

Purpose of the Study:

  • To investigate the mechanisms behind the prognostic benefits of cholesterol-lowering treatments.
  • To explore the role of vascular relaxation in CHD prevention.
  • To reconcile the observed clinical outcomes with plaque morphology changes.

Main Methods:

  • Review of clinical evidence on cholesterol-lowering therapy outcomes.
  • Analysis of experimental studies investigating hypercholesterolemia and vascular function.
  • Evaluation of data on vascular reactivity and plaque regression.

Main Results:

  • Cholesterol-lowering treatments show significant benefits in primary and secondary CHD prevention.
  • Observed improvements in prognosis are not fully explained by plaque regression alone.
  • Evidence suggests restoration of vascular relaxation capacity contributes to treatment efficacy.

Conclusions:

  • The beneficial effects of cholesterol-lowering therapy extend beyond plaque regression.
  • Restoration of endothelial function and vascular relaxation is a key mechanism.
  • This understanding refines therapeutic strategies for managing hypercholesterolemia and CHD.

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...